Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 5
2001 1
2002 4
2004 1
2005 3
2006 5
2007 5
2008 1
2009 3
2010 1
2011 2
2012 3
2013 3
2014 2
2015 1
2016 4
2017 6
2018 7
2019 13
2020 13
2021 16
2022 21
2023 18
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean n mohamed (2 results)?
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.
Legrand M, Falcone J, Cholley B, Charbonneau H, Delaporte A, Lemoine A, Garot M, Joosten A, Meistelman C, Cheron-Leroy D, Rives JP, Pastene B, Dewitte A, Sigaut S, Danguy des Deserts M, Truc C, Boisson M, Lasocki S, Cuvillon P, Schiff U, Jaber S, Le Guen M, Caillard A, Bar S, Pereira de Souza Neto E, Colas V, Dimache F, Girardot T, Jozefowicz E, Viquesnel S, Berthier F, Vicaut E, Gayat E; Stop-or-Not Trial Group. Legrand M, et al. JAMA. 2024 Sep 24;332(12):970-978. doi: 10.1001/jama.2024.17123. JAMA. 2024. PMID: 39212270 Free article. Clinical Trial.
INTERVENTION: Patients were randomized to continue use of RASIs (n = 1107) until the day of surgery or to discontinue use of RASIs 48 hours prior to surgery (ie, they would take the last dose 3 days before surgery) (n = 1115). ...
INTERVENTION: Patients were randomized to continue use of RASIs (n = 1107) until the day of surgery or to discontinue use of RASIs 48 …
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer.
Najminejad Z, Dehghani F, Mirzaei Y, Mer AH, Saghi SA, Abdolvahab MH, Bagheri N, Meyfour A, Jafari A, Jahandideh S, Gharibi T, Amirkhani Z, Delam H, Mashatan N, Shahsavarani H, Abdollahpour-Alitappeh M. Najminejad Z, et al. Mol Ther. 2023 Jul 5;31(7):1874-1903. doi: 10.1016/j.ymthe.2023.03.019. Epub 2023 Mar 22. Mol Ther. 2023. PMID: 36950736 Free PMC article. Review.
The evolving role of ECMO in liver transplantation.
Hogen R, Sedra AH, Motamed A, Emamaullee J. Hogen R, et al. Curr Opin Organ Transplant. 2021 Jun 1;26(3):333-338. doi: 10.1097/MOT.0000000000000874. Curr Opin Organ Transplant. 2021. PMID: 33782248 Free PMC article. Review.
Effects of Poly-N-isopropylacrylamide Microgels Containing Antibiofilm Substances on Pseudomonas aeruginosa Isolated from Chronic Wounds.
Etemadinia A, Seyfoori A, Rahimi Foroushani A, Mazaheri Nezhad Fard R, Bakhtiari R. Etemadinia A, et al. Avicenna J Med Biotechnol. 2022 Oct-Dec;14(4):317-320. Avicenna J Med Biotechnol. 2022. PMID: 36504567 Free PMC article.
The major aim of this study was to investigate effects of poly-N-isopropylacrylamide microgels (PNIPAM) on P. aeruginosa. METHODS: Totally, 100 P. aeruginosa strains were isolated from chronic wound infections. ...
The major aim of this study was to investigate effects of poly-N-isopropylacrylamide microgels (PNIPAM) on P. aeruginosa. METHODS: To …
Olfactory Dysfunction in Children: A Scoping Review.
Payandeh JE, Motamed M, Kirubalingam K, Chadha NK. Payandeh JE, et al. Otolaryngol Head Neck Surg. 2023 Dec;169(6):1399-1408. doi: 10.1002/ohn.415. Epub 2023 Jul 14. Otolaryngol Head Neck Surg. 2023. PMID: 37449420 Review.
Extracted data included study type, age/age-range of participants, gender, radiological evidence of olfactory dysfunction, types and results of smell tests used, etiology of olfactory loss, and therapies employed for olfactory loss. RESULTS: A total of 103 articles (n = 16 …
Extracted data included study type, age/age-range of participants, gender, radiological evidence of olfactory dysfunction, types and results …
Disseminated Lyme disease and dilated cardiomyopathy: A systematic review.
Motamed M, Liblik K, Miranda-Arboleda AF, Wamboldt R, Wang CN, Cingolani O, Rebman AW, Novak CB, Aucott JN, Farina JM, Baranchuk A. Motamed M, et al. Trends Cardiovasc Med. 2023 Nov;33(8):531-536. doi: 10.1016/j.tcm.2022.05.010. Epub 2022 Jun 3. Trends Cardiovasc Med. 2023. PMID: 35667636 Review.
A systematic review was conducted in PubMed, Embase, CENTRAL, and MEDLINE databases, after which a total of 11 observational studies (n = 771) were ultimately included for final data extraction. Although most studies (7/11) identified evidence associating Borrelia-infectio …
A systematic review was conducted in PubMed, Embase, CENTRAL, and MEDLINE databases, after which a total of 11 observational studies (n …
Cardiomyopathie de stress.
Motamed M, Nunes JT, Udell JA. Motamed M, et al. CMAJ. 2024 Dec 15;196(43):E1423-E1424. doi: 10.1503/cmaj.240269-f. CMAJ. 2024. PMID: 39681360 Free article. French. No abstract available.
Bone Metastasis Prognostic Factors in Breast Cancer.
Yazdani A, Dorri S, Atashi A, Shirafkan H, Zabolinezhad H. Yazdani A, et al. Breast Cancer (Auckl). 2019 Feb 22;13:1178223419830978. doi: 10.1177/1178223419830978. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 30828246 Free PMC article.
METHODS: In total, 1690 patients with breast cancer recorded between 2002 and 2012 in Motamed Cancer Institute, Tehran, Iran entered in the retrospective study. We studied age, menopausal status, histologic type, tumor size, number of cancerous axillary lymph nodes, serum …
METHODS: In total, 1690 patients with breast cancer recorded between 2002 and 2012 in Motamed Cancer Institute, Tehran, Iran entered …
134 results